Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Regimens for Serious Bacterial Infections in Young Infants in Community Settings
NCT00189384Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- Nov 2003
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of ceftriaxone in bacterial infection, sepsis, pneumonia, sponsored by Aga Khan University. Status: unknown.
02
Drugs
ceftriaxone
03
Conditions
bacterial infectionsepsispneumonia
Beyond the preview
Go deeper on NCT00189384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189384.